Breast DiseasesFibrocystic Breast DiseaseBreastCarcinoma, Ductal, BreastFibroadenomaBreast NeoplasmsAdenofibromaMammographyCarcinoma, Intraductal, NoninfiltratingBreast FeedingHyperplasiaBreast CystNipplesReceptors, EstrogenMenopauseCarcinoma in SituCarcinoma, LobularPrecancerous ConditionsReceptors, ProgesteroneRisk FactorsBreast Neoplasms, MaleCase-Control StudiesUltrasonography, MammaryMastectomyBiopsy, NeedleTumor Markers, BiologicalNeoplasm InvasivenessBiopsyCell Line, TumorBreast ImplantsReceptor, erbB-2MastitisBreast Self-ExaminationPrognosisPostmenopauseEstrogensTamoxifenCarcinomaRiskPalpationNeoplasm MetastasisAge FactorsPremenopauseImmunohistochemistryProspective StudiesGene Expression Regulation, NeoplasticLymphatic MetastasisParityNeoplasm StagingNeoplasm ProteinsCohort StudiesMenstruationOdds RatioMenarcheIncidenceRisk AssessmentTime FactorsEstrogen Replacement TherapyBody FluidsSensitivity and SpecificityGenes, BRCA1Mass ScreeningAntineoplastic Agents, HormonalProportional Hazards ModelsFollow-Up StudiesCell ProliferationCathepsin DMastectomy, SegmentalMilk, HumanMammaplastyTumor Cells, CulturedProgestinsRetrospective StudiesConfidence IntervalsDisease ProgressionChemotherapy, AdjuvantMCF-7 CellsMammary Glands, HumanEstrogen Receptor alphaAntineoplastic AgentsCell Transformation, NeoplasticImmunoenzyme TechniquesMammary Neoplasms, ExperimentalQuestionnairesBreast ImplantationBRCA2 ProteinBRCA1 ProteinAxillaFamily HealthMultivariate AnalysisGenes, BRCA2Neoplasms, Hormone-DependentOutpatient Clinics, HospitalChinaUnited StatesTriple Negative Breast NeoplasmsLogistic ModelsInflammatory Breast NeoplasmsGenes, erbB-2Antibodies, Monoclonal